Literature DB >> 1464880

Acute nonlymphocytic leukemia after treatment of systemic lupus erythematosus with immunosuppressive agents.

S Vasquez1, A F Kavanaugh, N R Schneider, M C Wacholtz, P E Lipsky.   

Abstract

We describe a case of acute nonlymphocytic leukemia with inversion of chromosome 16 in a patient with systemic lupus erythematosus treated with immunosuppressive agents including azathioprine and cyclophosphamide. Although the leukemia may have been caused by other factors, it is worth noting the potential association of this malignancy with immunosuppressive therapy.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1464880

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  9 in total

Review 1.  Myeloid disorders after autoimmune disease.

Authors:  Prajwal C Boddu; Amer M Zeidan
Journal:  Best Pract Res Clin Haematol       Date:  2019-02-07       Impact factor: 3.020

Review 2.  Acute myeloid leukemia developing in patients with autoimmune diseases.

Authors:  Safaa M Ramadan; Tamer M Fouad; Valentina Summa; Syed Kh Hasan; Francesco Lo-Coco
Journal:  Haematologica       Date:  2011-12-16       Impact factor: 9.941

3.  Secondary acute myeloid leukaemia with 7q- complicating azathioprine treatment for rheumatoid arthritis.

Authors:  C C Mok; Y L Kwong; C S Lau
Journal:  Ann Rheum Dis       Date:  1995-02       Impact factor: 19.103

4.  Acute megakaryoblastic leukaemia in a patient with systemic lupus erythematosus.

Authors:  M Colović; G Janković; V Lazarević; A Novak
Journal:  Med Oncol       Date:  1997-03       Impact factor: 3.064

5.  Renal cell carcinoma with proliferative lupus nephritis.

Authors:  Koh-Wei Wong
Journal:  BMJ Case Rep       Date:  2015-01-16

6.  Cancer risk in a cohort of patients with systemic lupus erythematosus (SLE) in California.

Authors:  Arti Parikh-Patel; Richard H White; Mark Allen; Rosemary Cress
Journal:  Cancer Causes Control       Date:  2008-04-02       Impact factor: 2.506

7.  Clinical and laboratory observation systemic lupus erythematosus and acute lymphocytic leukemia: An unusual case.

Authors:  Anu Maheshwari; Meenu Pandey; Bimbadhar Rath; Jagdish Chandra; Smita Singh; Sunita Sharma
Journal:  Indian J Med Paediatr Oncol       Date:  2011-07

8.  Efficacy and Safety of Cyclophosphamide Treatment in Severe Juvenile Dermatomyositis Shown by Marginal Structural Modeling.

Authors:  Claire T Deakin; Raquel Campanilho-Marques; Stefania Simou; Elena Moraitis; Lucy R Wedderburn; Eleanor Pullenayegum; Clarissa A Pilkington
Journal:  Arthritis Rheumatol       Date:  2018-03-25       Impact factor: 10.995

9.  Systemic lupus erythematosus following acute lymphocytic leukemia.

Authors:  Sulaiman M Al Mayouf; Amal Seraihy
Journal:  Ann Saudi Med       Date:  2006 Jan-Feb       Impact factor: 1.526

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.